Research Article
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray
Table 3
Univariate analysis for recurrence free survival and overall survival.
| Variables | Median RFS (months) | P | Median OS (months) | P |
| Age | | 0.869 | | 0.897 | >50 | 132 | | 132 | | ≤50 | 63 | | 63 | | Stage | | < 0.001 | | < 0.001 | Early (I-II) | 132 | | 132 | | Advanced (III-IV) | 38 | | 38 | | Ascites | | 0.946 | | 0.878 | Yes | 61 | | 61 | | No | 38 | | 38 | | Chemotherapy resistance | | 0.032 | | 0.032 | Yes | 32 | | 33 | | No | undefined | | undefined | | ICAM-1 expression | | 0.005 | | 0.005 | Overexpression | 47 | | 47 | | Low expression | undefined | | undefined | |
|
|
Abbreviations. RFS: recurrence free survival; OS: overall survival.
|